Plus   Neg

Heidrick & Struggles Q4 Profit Down

Heidrick & Struggles International Inc. (HSII) Monday reported fourth-quarter net income of $5.54 million or $0.28 per share, down from $10.55 million or $0.54 per share last year.

Adjusted earnings for the quarter were $0.59 per share, up from $0.54 per share last year.

Total revenues dropped 12% to $162.2 million from $184.6 million last year.

Analysts polled by Thomson Reuters estimated earnings of $0.31 per share on revenues of $146.19 million.

Looking forward, the company expects first-quarter revenue of between $160 million and $170 million. Analysts currently estimate revenues of $142.14 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies. Beverages giant Coca-Cola reported a 19 percent decline in profit for the second quarter from last year as a revenue growth of 5 percent and improved margins were offset by higher income taxes and interest expense. However, adjusted earnings per share and revenues topped analysts' expectations. The company also maintained its adjusted earnings and organic revenue growth outlook for fiscal 2021.
Follow RTT